TY - JOUR
T1 - Clinical practice guidelines for the care of girls and women with Turner syndrome
T2 - Proceedings from the 2016 Cincinnati International Turner Syndrome Meeting
AU - On behalf of the International Turner Syndrome Consensus Group
AU - Gravholt, Claus H.
AU - Andersen, Niels H.
AU - Conway, Gerard S.
AU - Dekkers, Olaf M.
AU - Geffner, Mitchell E.
AU - Klein, Karen O.
AU - Lin, Angela E.
AU - Mauras, Nelly
AU - Quigley, Charmian A.
AU - Rubin, Karen
AU - Sandberg, David E.
AU - Sas, Theo C.J.
AU - Silberbach, Michael
AU - Söderström-Anttila, Viveca
AU - Stochholm, Kirstine
AU - Van Alfen-Van DerVelden, Janielle A.
AU - Woelfle, Joachim
AU - Backeljauw, Philippe F.
AU - Bamba, Vaneeta
AU - Bonfig, Natalie Brobin
AU - Braverman, Alan C.
AU - Breech, Lesley L.
AU - Brickman, Wendy J.
AU - Brown, Nicole M.
AU - Bryant, Nancy
AU - Cernich, Joseph
AU - Chernausek, Steven
AU - Christin-Maitre, Sophie
AU - Corathers, Sarah D.
AU - Crawford, Anne
AU - Crenshaw, Melissa L.
AU - Davenport, Marsha L.
AU - De Backer, Julie
AU - Eagle, Kim
AU - Gawlik, Aneta
AU - Gutmark-Little, Iris
AU - Hay, Darlene
AU - Hiratzka, Loren
AU - Hong, David S.
AU - Hovatta, Outi
AU - Hultcrantz, Malou
AU - Johnson, Walter H.
AU - Kanaka-Gantenbein, Christina
AU - Karnis, Megan F.
AU - Knickmeyer, Rebecca Christine
AU - Kristrøm, Berit
AU - Lajiness-O'Neill, Renee R.
AU - Landin-Wilhelmsen, Kerstin
AU - Law, Jennifer R.
AU - Lippe, Barbara
N1 - Funding Information:
These guidelines were sponsored primarily by the ESE, and co-sponsored by PES, ESPE and ES. Furthermore, ESHRE and ESC supported their own delegates for the meeting, and additional support was obtained from the AHA, the National Institute of Child Health and Human Development (NICHD grant #1R13HD089663), the National Center for Advancing Translational Sciences, Cincinnati Children’s Hospital Medical Center’s TS Foundation, as well as several advocacy groups (TS Society of the United States, the TS Global Alliance and the Turner Resource Network).
Publisher Copyright:
© 2017 European Society of Endocrinology.
PY - 2017/9
Y1 - 2017/9
N2 - Turner syndrome affects 25-50 per 100,000 females and can involve multiple organs through all stages of life, necessitating multidisciplinary approach to care. Previous guidelines have highlighted this, but numerous important advances have been noted recently. These advances cover all specialty fields involved in the care of girls and women with TS. This paper is based on an international effort that started with exploratory meetings in 2014 in both Europe and the USA, and culminated with a Consensus Meeting held in Cincinnati, Ohio, USA in July 2016. Prior to this meeting, five groups each addressed important areas in TS care: 1) diagnostic and genetic issues, 2) growth and development during childhood and adolescence, 3) congenital and acquired cardiovascular disease, 4) transition and adult care, and 5) other comorbidities and neurocognitive issues. These groups produced proposals for the present guidelines. Additionally, four pertinent questions were submitted for formal GRADE (Grading of Recommendations, Assessment, Development and Evaluation) evaluation with a separate systematic review of the literature. These four questions related to the efficacy and most optimal treatment of short stature, infertility, hypertension, and hormonal replacement therapy. The guidelines project was initiated by the European Society of Endocrinology and the Pediatric Endocrine Society, in collaboration with the European Society for Paediatric Endocrinology, the Endocrine Society, the European Society of Human Reproduction and Embryology, the American Heart Association, the Society for Endocrinology, and the European Society of Cardiology. The guideline has been formally endorsed by the European Society of Endocrinology, the Pediatric Endocrine Society, the European Society for Paediatric Endocrinology, the European Society of Human Reproduction and Embryology and the Endocrine Society. Advocacy groups appointed representatives who participated in pre-meeting discussions and in the consensus meeting.
AB - Turner syndrome affects 25-50 per 100,000 females and can involve multiple organs through all stages of life, necessitating multidisciplinary approach to care. Previous guidelines have highlighted this, but numerous important advances have been noted recently. These advances cover all specialty fields involved in the care of girls and women with TS. This paper is based on an international effort that started with exploratory meetings in 2014 in both Europe and the USA, and culminated with a Consensus Meeting held in Cincinnati, Ohio, USA in July 2016. Prior to this meeting, five groups each addressed important areas in TS care: 1) diagnostic and genetic issues, 2) growth and development during childhood and adolescence, 3) congenital and acquired cardiovascular disease, 4) transition and adult care, and 5) other comorbidities and neurocognitive issues. These groups produced proposals for the present guidelines. Additionally, four pertinent questions were submitted for formal GRADE (Grading of Recommendations, Assessment, Development and Evaluation) evaluation with a separate systematic review of the literature. These four questions related to the efficacy and most optimal treatment of short stature, infertility, hypertension, and hormonal replacement therapy. The guidelines project was initiated by the European Society of Endocrinology and the Pediatric Endocrine Society, in collaboration with the European Society for Paediatric Endocrinology, the Endocrine Society, the European Society of Human Reproduction and Embryology, the American Heart Association, the Society for Endocrinology, and the European Society of Cardiology. The guideline has been formally endorsed by the European Society of Endocrinology, the Pediatric Endocrine Society, the European Society for Paediatric Endocrinology, the European Society of Human Reproduction and Embryology and the Endocrine Society. Advocacy groups appointed representatives who participated in pre-meeting discussions and in the consensus meeting.
UR - http://www.scopus.com/inward/record.url?scp=85028665160&partnerID=8YFLogxK
U2 - 10.1530/EJE-17-0430
DO - 10.1530/EJE-17-0430
M3 - Article
C2 - 28705803
AN - SCOPUS:85028665160
SN - 0804-4643
VL - 177
SP - G1-G70
JO - European Journal of Endocrinology
JF - European Journal of Endocrinology
IS - 3
ER -